Litchman Manuel MD 4
4 · MUSTANG BIO, INC. · Filed Apr 28, 2025
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Tax Payment
COMMON STOCK
2025-04-24$1.24/sh−27$33→ 1,634 total
Footnotes (2)
- [F1]27 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
- [F2]Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.